Glioblastoma: open trials in Taiwan

• NCT07386002

  The GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma

  Trial Treatment · Phase 2 · T-MAXIMUM Pharmaceutical Inc

  Hualien Tzu Chi Hospital, Hualien City · Chang Gung Memorial Hospital, Kaohsiung, Kaohsiung City · Chang Gung Memorial Hospital, Linkou, Taoyuan

  Registry updated 2026-10-14

• NCT04094610

  A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  Taipei Medical University Hospital, Taipei · Taipei

  Registry updated 2026-09-25

• NCT04115761

  Evaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients

  Trial Treatment · Phase 2 · Ever Supreme Bio Technology Co., Ltd.

  China Medical University Hospital, Taichung · Taichung Veterans General Hospital, Taichung · Chang-Gung Memorial Hospital at Lin-Ko, Taoyuan

  Registry updated 2026-09-24

• NCT07569042

  A Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma

  Trial Treatment · Phase 1/2 · Novelwise Pharmaceutical Corporation

  Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · Linkou Chang-Gung Memorial Hospital, Taoyuan City

  Registry updated 2026-05-06

• NCT06012695

  NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma

  Trial Treatment · Phase 1/2 · Novelwise Pharmaceutical Corporation

  Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung City · Taichung Veterans General Hospital, Taichung · Koo Foundation Sun Yat-Sen Cancer Center, Taipei · Linkou Chang-Gung Memorial Hospital, Taoyuan City

  Registry updated 2026-04-29

• NCT06496971

  A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

  Trial Treatment · Phase 3 · NaviFUS Corporation

  National Taiwan University Hospital, Taipei · Linkou Chang Gung Memorial Hospital, Taoyuan

  Registry updated 2026-04-09

• NCT03175224

  APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  Trial Treatment · Phase 2 · Apollomics Inc.

  National Taiwan University Hospital, Taipei

  Registry updated 2025-06-27

All Glioblastoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error